Pharmacological disease models

Filters

Small molecules and excitotoxic agents can be used to pharmacologically induce disease models such as epilepsy, Parkinson's Disease, catalepsy, Schizophrenia, pain and diabetes models. Researchers can save up to 50% on excitotoxic agents - they are up to half the price of other suppliers.

Items 131-140 of 320

Set Descending Direction
  1. Description:

    Competitive Tryptophan 2-monooxygenase oxidase inhibitor

    Purity:

    >98%

    Pack:
    100mg
    Price:
    $86
    Qty:
  2. Pack:
    10mg
    Price:
    $169
    Qty:
  3. Pack:
    10mg
    Price:
    $165
    Qty:
    Pack:
    50mg
    Price:
    $575
    Qty:
  4. ITD 1 (HB3446)

    Description:

    Selective TGF-β signaling inhibitor. Induces cardiomyocyte differentiation in ESCs.

    Purity:

    >98%

    Pack:
    10mg
    Price:
    $213
    Qty:
    Pack:
    50mg
    Price:
    $824
    Qty:
  5. IWP 2 (HB0344)

    Description:

    Potent Wnt pathway inhibitor and PORCN inhibitor. Suppresses R1 ESC self-renewal. Used in the production of cardiac organoids.

    Purity:

    >98%

    Pack:
    25mg
    Price:
    $359
    Qty:
  6. IWP 4 (HB3066)

    Description:

    Potent Wnt/β-catenin signaling inhibitor. Induces cardiomyocyte differentiation of hESCs and iPSCs.

    Purity:

    >98%

    Pack:
    25mg
    Price:
    $534
    Qty:
  7. IWP L6 (HB3134)

    Description:

    Potent PORCN inhibitor. Supresses R1 ESCs self renewal.

    Purity:

    >98%

    Pack:
    10mg
    Price:
    $205
    Qty:
    Pack:
    50mg
    Price:
    $798
    Qty:
  8. Pack:
    10mg
    Price:
    $135
    Qty:
Page